These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 15375382

  • 1. Depletion of CD25+ cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein.
    Mincheff M, Zoubak S, Altankova I, Tchakarov S, Pogribnyy P, Makogonenko Y, Botev C, Meryman HT.
    Cancer Gene Ther; 2005 Feb; 12(2):185-97. PubMed ID: 15375382
    [Abstract] [Full Text] [Related]

  • 2. Human dendritic cells genetically engineered to express cytosolically retained fragment of prostate-specific membrane antigen prime cytotoxic T-cell responses to multiple epitopes.
    Mincheff M, Zoubak S, Altankova I, Tchakarov S, Makogonenko Y, Botev C, Ignatova I, Dimitrov R, Madarzhieva K, Hammett M, Pomakov Y, Meryman H, Lissitchkov T.
    Cancer Gene Ther; 2003 Dec; 10(12):907-17. PubMed ID: 14712317
    [Abstract] [Full Text] [Related]

  • 3. Human dendritic cells genetically engineered to express a melanoma polyepitope DNA vaccine induce multiple cytotoxic T-cell responses.
    Smith SG, Patel PM, Porte J, Selby PJ, Jackson AM.
    Clin Cancer Res; 2001 Dec; 7(12):4253-61. PubMed ID: 11751527
    [Abstract] [Full Text] [Related]

  • 4. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
    Lundberg K, Roos AK, Pavlenko M, Leder C, Wehrum D, Guevara-Patiño J, Andersen RS, Pisa P.
    Vaccine; 2009 Mar 04; 27(10):1557-65. PubMed ID: 19171173
    [Abstract] [Full Text] [Related]

  • 5. Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigen.
    Terasawa H, Tsang KY, Gulley J, Arlen P, Schlom J.
    Clin Cancer Res; 2002 Jan 04; 8(1):41-53. PubMed ID: 11801539
    [Abstract] [Full Text] [Related]

  • 6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 04; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 7. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
    Heine A, Grünebach F, Holderried T, Appel S, Weck MM, Dörfel D, Sinzger C, Brossart P.
    Mol Ther; 2006 Feb 04; 13(2):280-8. PubMed ID: 16219490
    [Abstract] [Full Text] [Related]

  • 8. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.
    Dell K, Klein C, Gissmann L.
    Antivir Ther; 2008 Feb 04; 13(4):495-509. PubMed ID: 18672528
    [Abstract] [Full Text] [Related]

  • 9. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

  • 10. Induction of primary human CD8+ T lymphocyte responses in vitro using dendritic cells.
    Zarling AL, Johnson JG, Hoffman RW, Lee DR.
    J Immunol; 1999 May 01; 162(9):5197-204. PubMed ID: 10227993
    [Abstract] [Full Text] [Related]

  • 11. Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens.
    Qin H, Zhou C, Wang D, Ma W, Liang X, Lin C, Zhang Y, Zhang S.
    Immunol Lett; 2005 Jun 15; 99(1):85-93. PubMed ID: 15894116
    [Abstract] [Full Text] [Related]

  • 12. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S, Lee JB, Lee GK, Chang J.
    Prostate; 2009 Jun 15; 69(9):938-48. PubMed ID: 19267351
    [Abstract] [Full Text] [Related]

  • 13. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J, Jiang S, Tanriver Y, Leung E, Lombardi G, Lechler RI.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1883-8. PubMed ID: 17161341
    [Abstract] [Full Text] [Related]

  • 14. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ, Dao T, Pinilla-Ibarz J, Korontsvit T, Zakhaleva V, Zhang RH, Maslak P, Scheinberg DA.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [Abstract] [Full Text] [Related]

  • 15. Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses.
    Kuang Y, Weng X, Liu X, Zhu H, Chen Z, Jiang B, Chen H.
    Cancer Lett; 2010 Jul 28; 293(2):254-62. PubMed ID: 20149524
    [Abstract] [Full Text] [Related]

  • 16. High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals.
    Forsberg O, Carlsson B, Malmström PU, Ullenhag G, Tötterman TH, Essand M.
    Prostate; 2009 Jan 01; 69(1):70-81. PubMed ID: 18814178
    [Abstract] [Full Text] [Related]

  • 17. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM.
    Int Immunopharmacol; 2003 Oct 01; 3(10-11):1401-11. PubMed ID: 12946436
    [Abstract] [Full Text] [Related]

  • 18. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
    Mochimaru H, Nagai N, Hasegawa G, Kudo-Saito C, Yaguchi T, Usui Y, Kurihara T, Koto T, Satofuka S, Shinoda H, Ozawa Y, Tsubota K, Kawakami Y, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Oct 01; 48(10):4795-801. PubMed ID: 17898306
    [Abstract] [Full Text] [Related]

  • 19. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
    Shilyansky J, Jacobs P, Doffek K, Sugg SL.
    J Pediatr Surg; 2007 Jan 01; 42(1):54-61; discussion 61. PubMed ID: 17208541
    [Abstract] [Full Text] [Related]

  • 20. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice.
    Sakai Y, Morrison BJ, Burke JD, Park JM, Terabe M, Janik JE, Forni G, Berzofsky JA, Morris JC.
    Cancer Res; 2004 Nov 01; 64(21):8022-8. PubMed ID: 15520211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.